•  
  • Technológia
    NGS NGS
    Microarrays Microarrays
    Real - Time PCR Real - Time PCR
    Automatizálás Automatizálás
  • Termékek
    Készülékek
    • NGS szekvenáló berendezések
    • Microarray berendezések
    • Automatizált mintatároló rendszerek
    • Bioimaging készülékek
    • PCR, Real-time PCR készülékek
    • NGS könyvtár preparálás
    • Xenium Analyzer
    Reagensek
    • NGS reagensek
    • TSO500 HRD
    • Nukleinsav izoláló reagensek
    • PCR reagensek
    • KASP genotipizáló reagensek
    • Long-Read Technológia
    • WES sequencing
    Case report: rapid WGS
    • Rapid teljes genom szekvenálás (rWGS)
    Adatelemző eszközök
    • Professzionális másodlagos adatelemzés
    • Adatkezelés és elemzés a felhőben
    • Az örökletes betegségek variánsainak értelmezése
    • Variánsok értelmezése az onkológiában
    • NGS LIMS
  • Cégek
    10x GENOMICS
    Arrow Diagnostics
    Covaris
    Diagenode
    DNA Diagnostic A/S
    IAB
    Illumina
    Invivoscribe technologies
    LGC Genomics
    Pillar Bioscience
    SeqOne Genomics
    Vitrolife
    Yourgene Health
  • Kontaktok
    Általános kapcsolatfelvétel a GeneTiCA-val GeneTiCA
    Termékfelelős Termékfelelős
    Applikációs support Applikációs support
    Technikai support Technikai support
    Automatizálás Automatizálás
  •  
    Genetica.CZGenetica.SKGenetica.HU
  •  
  •  
https://www.genetica.cz +420 272 701 055 Služeb 4 Praha

GeneTiCA Hungary Kft. - főoldal

How the UK is setting new standards for genomic research and better health care

Read more
Banner 1
Banner 2
Banner 3

Hírek

06. 12. 2023 - Shriners Children’s big bet on the future of specialized pediatric care
05. 12. 2023 - WEBINAR: Wellcome Sanger Institute evaluation of Illumina Complete Long Reads​
28. 11. 2023 - Preventing postoperative infections one NGS assay at a time
27. 11. 2023 - Targeted panels paint a partial picture. CGP completes the portrait.
22. 11. 2023 - EACR Industry Webinar with Illumina: New to NGS Live Panel Discussion
20. 11. 2023 - WEBINAR: Exploring Microbiomes and Cancer Immunology
13. 11. 2023 - Take your research higher with NGS - NEW Introduction to NGS eBook
07. 11. 2023 - VIDEO: Illumina highlights the importance of HRD testing at ESMO 2023
06. 11. 2023 - Recent genomic discoveries and advances
03. 11. 2023 - Illumina launches advanced liquid biopsy assay to enable comprehensive genomic profiling of solid tumors
31. 10. 2023 - VIDEO: Testing for NTRK fusions in solid tumors
30. 10. 2023 - Liquid Biopsy in Cancer Research eBook
24. 10. 2023 - What the diagnostic odyssey looks like—and how we can end it
23. 10. 2023 - What is Metatranscriptomics?
17. 10. 2023 - Q&A: An Illumina intern’s shift from academia to industry
16. 10. 2023 - The Polygenic Risk Score (PRS) Software Predict module and Infinium™ Global Diversity Array provides streamline genotype-to-risk prediction
11. 10. 2023 - It’s time to increase access to molecular testing for people with ovarian cancer
09. 10. 2023 - Achieve the next level of scale, cost efficiency, and sequencing capabilities with XLEAP-SBS coming in early 2024 - driving science forward faster than ever
06. 10. 2023 - Whole-genome sequencing (WGS) breaking frontiers on patient care
03. 10. 2023 - WEBINAR: Unlock the next wave of genomic discovery with NovaSeq X
26. 09. 2023 - Why pathogen surveillance is critical during a “tripledemic”
25. 09. 2023 - WEBINAR: Pathogen Genomics Surveillance with New Illumina panels
19. 09. 2023 - Insights from Dublin: Fostering precision oncology for better patient outcomes
18. 09. 2023 - The Greater Good Initiative rewards researchers like you, who are conducting ground-breaking research to improve sustainability and productivity of agricultural species
13. 09. 2023 - Illumina User Group Meeting – Boston (online option available)
11. 09. 2023 - European Congress of Pathology 2023 - No patient left behind: Importance of Comprehensive Genomic Profiling (CGP) and incorporating rare biomarkers into your practice (also available as on-demand)
07. 09. 2023 - WEBINAR: Live from the Customer Experience Lab in Amsterdam: GeoMx DSP from sample to data and more
06. 09. 2023 - Illumina User Group Meeting – Bay Area (online option available)
04. 09. 2023 - Recent genomic discoveries and advances
29. 08. 2023 - CGP in practice: growing utility and future perspective
28. 08. 2023 - Microbial Profiling – Harness the Potential​ of Metagenomics & Metatranscriptomics
23. 08. 2023 - Budi Hermawan’s long fight against tuberculosis
21. 08. 2023 - WEBINAR: Seq&Treat - enabling targeted NGS for detection of drug-resistant tuberculosis
15. 08. 2023 - How genetic technologies can empower more people with information
14. 08. 2023 - WEBINAR: Environmental DNA for biomonitoring of aquatic ecosystems
09. 08. 2023 - New research shows CGP is most effective as a standalone test
07. 08. 2023 - Prospective study supports use of WGTS in routine diagnostics of bone and soft tissue tumors
01. 08. 2023 - WEBINAR: Wellcome Sanger Institute evaluation of Illumina Complete Long Reads​
31. 07. 2023 - What is Metatranscriptomics?​
26. 07. 2023 - New AI tool searches genetic haystacks to find disease-causing variants
24. 07. 2023 - WEBINARS: RNA Sequencing: From Data to Insights
20. 07. 2023 - The Alliance for Genomic Discovery announces founding biopharma members: AbbVie, Amgen, AstraZeneca, Bayer, and Merck
18. 07. 2023 - Hundreds of new primate genomes offer window into human health—and our past
17. 07. 2023 - Illumina Complete Long Reads software analysis workflow for human WGS
14. 07. 2023 - Illumina DRAGEN 4.2 delivers most accurate and comprehensive coverage of the genome, powering greater applications and discovery
11. 07. 2023 - A liquid biopsy study offers new hope for lung cancer patients
10. 07. 2023 - Customer Experience with the NextSeq 2000
04. 07. 2023 - Addressing the genomics education gap
03. 07. 2023 - NextSeq 1000 and 2000: Product updates and key applications
27. 06. 2023 - Highlights from Glasgow: Educating and promoting the impact of WGS
26. 06. 2023 - Genomics in medicine - Xpeer
20. 06. 2023 - CGP validated in triple-negative breast cancer patients
19. 06. 2023 - Customer Experience with the NextSeq 2000
13. 06. 2023 - WEBINAR: NextSeq 1000/2000: Longer reads and extended informatics
12. 06. 2023 - Whole-genome sequencing (WGS) breaking frontiers on patient care
05. 06. 2023 - We are prepared for the IVDR transition - are you?
02. 06. 2023 - Illumina unveils AI software to predict disease-causing genetic mutations in patients
01. 06. 2023 - Real-world study data reveals better outcomes for cancer patients who receive comprehensive genomic testing
31. 05. 2023 - The future of precision metagenomics in treating infectious disease
29. 05. 2023 - VIDEO: Environmental DNA for biomonitoring of aquatic ecosystems
24. 05. 2023 - Illumina User Group Meeting – Toronto (an option to attend virtually)
22. 05. 2023 - WEBINAR: High throughput gene expression profiling with spatial resolution
17. 05. 2023 - Illumina's genomic technologies enable better pathogen preparedness and response
16. 05. 2023 - Illumina User Group Meeting – Houston (an option to attend virtually)
15. 05. 2023 - WEBINAR: Preventative Genomics: Future Impact on Healthcare
10. 05. 2023 - WEBINAR: Expand single cell possibilities with advanced chemistry for fresh or fixed samples
08. 05. 2023 - Genomic Sequencing for the next generation
04. 05. 2023 - WEBINAR: Experience the power of Xenium
04. 05. 2023 - VIDEO: Illumina Complete Long Reads
02. 05. 2023 - Illumina increases equitable access to STEM education, reaching over 1 million learners
28. 04. 2023 - WEBINAR: Revealing Illumina’s Innovation Updates
26. 04. 2023 - WEBINAR: Illumina User Group Meeting – Rockville
25. 04. 2023 - WEBINAR: We are prepared for the IVDR transition - are you?
20. 04. 2023 - Illumina celebrates 25 years of innovation
19. 04. 2023 - Rady’s Frontiers in Pediatric Genomic Medicine Conference 2023
18. 04. 2023 - 25 greatest impacts in 25 years: Illumina and the evolution of genomics
17. 04. 2023 - Revealing the most challenging regions of the genome
13. 04. 2023 - Illumina's cloud-based informatics programs recognized for robust, international data privacy protections
12. 04. 2023 - Illumina and Henry Ford Health team up to study impact of comprehensive genomic testing for cardiovascular patients
11. 04. 2023 - Illumina's revolutionary NovaSeq X exceeds 200th order milestone in first quarter 2023
11. 04. 2023 - WEBINAR: Epigenetics: the full picture
04. 04. 2023 - Illumina launches new software to enable tertiary analysis for oncology applications, and soon rare disease
03. 04. 2023 - Discoveries in Immunology at the single-cell level
29. 03. 2023 - VIDEO: What is homologous recombination deficiency (HRD)?
27. 03. 2023 - Using Single-Cell Sequencing to Investigate Murine COVID-19 Mortality
20. 03. 2023 - Illumina launches its first product enabling long- and short-read sequencing on one instrument
15. 03. 2023 - Children’s Mercy Kansas City tackles the unique complexity of pediatric cancer
13. 03. 2023 - Introducing the NovaSeq X and X Plus Sequencing Systems
13. 03. 2023 - Working to solve rare disease and support patients
07. 03. 2023 - Using whole-genome sequencing to study early-onset Parkinson’s disease
06. 03. 2023 - Illumina and Myriad Genetics expand partnership to broaden access to HRD testing in the United States
27. 02. 2023 - Find the next breakthrough cancer therapeutic with Visium
20. 02. 2023 - WEBINAR: Whole-Genome Sequencing and the way forward for Paediatrics
15. 02. 2023 - WEBINAR: NGS-Based Homologous Recombination Deficiency Assessment with a Semi-Automated Protocol
15. 02. 2023 - Illumina delivers first NovaSeq X Plus sequencer to the Broad Institute
14. 02. 2023 - Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2022
13. 02. 2023 - How organizations around the world are closing the cancer care gap
09. 02. 2023 - WEBINAR: Respiratory Pathogen ID and AMR Panel – A precision metagenomics solution for respiratory pathogen identification
08. 02. 2023 - Illumina Appoints Joydeep Goswami Chief Financial Officer
07. 02. 2023 - VIDEO: UK Festival of Genomics & Biodata inspires and connects industry leaders
01. 02. 2023 - WEBINAR: Multiomic profiling of patient-derived subclones identifies aggressive cellular subpopulations in paediatric diffuse high-grade gliomas
31. 01. 2023 - Sequencing within reach, for any application
26. 01. 2023 - WEBINAR: Empower murine studies to accelerate cancer research
17. 01. 2023 - Illumina to Announce Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 7, 2023
16. 01. 2023 - Meet NovaSeq X Series
16. 01. 2023 - Illumina and Nashville Biosciences Announce Sequencing Agreement with Amgen
12. 01. 2023 - Does Your Dog Have Nine Lives, Too? This DNA Test Can Tell You
10. 01. 2023 - WEBINAR: Clonal evolution in breast cancer: application of ultra-deep single cell multiomic sequencing
09. 01. 2023 - Experts in Hungary and the Czech Republic share their experiences using Comprehensive Genomic Profiling
02. 01. 2023 - Illumina Ranks Among Top Scores on Dow Jones Sustainability Index and CDP
22. 12. 2022 - The Next Frontier in Carbon Capture is a Hungry Bacterium
15. 12. 2022 - WEBINAR: A multi-species, low-cost, genome-wide genotyping platform to support molecular breeding in small grains
06. 12. 2022 - Addressing the Shortage of Genetic Counselors with Software
28. 11. 2022 - WEBINAR: Shining a Light on Rare Disease
22. 11. 2022 - Addressing the Shortage of Genetic Counselors with Software
21. 11. 2022 - RNA Sequencing Critical to Identifying Key Fusions for Oncology Patients
14. 11. 2022 - Greenwood Genetic Center: Answering the Unanswered
08. 11. 2022 - Can Genomics Stop the World’s Leading Cause of Death?
31. 10. 2022 - WEBINAR: Xenium In Situ - Welcome to the revolution
20. 10. 2022 - WEBINAR: Resolving tumor microenvironment heterogeneity at the single cell level from fixed samples
17. 10. 2022 - Illumina Unveils Revolutionary NovaSeq X Series to Rapidly Accelerate Genomic Discoveries and Improve Human He
10. 10. 2022 - Illumina Introduces Multiple Breakthrough Sequencing Innovations at Inaugural Genomics Forum
03. 10. 2022 - The Illumina Innovation Roadmap: Empowering Genomic Breakthroughs
26. 09. 2022 - Illumina Genomics Forum to Convene Leading Visionaries to Explore Architecting Health's Radically New Infrastr
19. 09. 2022 - Illumina Genomics Forum
12. 09. 2022 - WEBINAR: An Introduction to Sequencing
06. 09. 2022 - WEBINAR: Where do I begin with IVDR? Illumina - The basics, the transition and how we can help
31. 08. 2022 - WEBINAR: Metatranscriptomic Analysis of the Skin and Gut Microbiomes of an Isolated Amazonian Community
29. 08. 2022 - 50 Patents in 25 Years: A Look Back on the Sequence of Dr. Colin Barnes’s Career
22. 08. 2022 - Illumina Genomics Forum to Feature Bill Gates and Distinguished Health Leaders Addressing Need for Global Acce
16. 08. 2022 - Illumina Unveils its Most Accurate and Comprehensive Secondary Analysis Platform
08. 08. 2022 - The Soil Secrets That Could Help Feed the World
04. 08. 2022 - Inaugural Illumina Genomics Forum with a Conversation with Former U.S. President Barack Obama
26. 07. 2022 - Illumina Invests in £30M Venture Fund to Advance Breakthroughs in Human Health
19. 07. 2022 - Illumina Research Test Codeveloped with Merck to Unlock Deeper Insights into the Tumor Genome
12. 07. 2022 - Australia’s PrOSPeCT Project Is Sequencing Thousands of Cancer Patients
04. 07. 2022 - AI Drives Data Insights for Doctors and their Patients
27. 06. 2022 - Video: European Customers Share Their Success Stories
20. 06. 2022 - “All Patients Should Have Their Tumor Sequenced At Least Once”
15. 06. 2022 - WEBINAR: Single-cell transcriptomic landscape in Alzheimer’s disease
06. 06. 2022 - Illumina Introduces New Pan-Cancer Companion Diagnostic to Match Patients to Targeted Therapy
31. 05. 2022 - Baby Fitz’s Life-Saving Diagnosis Through Whole-Genome Sequencing
23. 05. 2022 - WEBINAR: A comprehensive solution for virtually any application: NextSeq 1000 and 2000
16. 05. 2022 - 1st 10x Genomics Experience Meeting 2022
09. 05. 2022 - WEBINAR: Introducing Illumina Infinity long read technology
02. 05. 2022 - WEBINAR: Advancements in translational biomarker identification from cell-free RNA
25. 04. 2022 - WEBINAR: Can genomic surveillance detect the next pandemic before it’s too late?
14. 04. 2022 - For Kidney Transplant Recipients, a More Accurate and Tailored Care Plan
07. 04. 2022 - Can Wastewater Surveillance Protect Public Health?
30. 03. 2022 - WEBINAR: Enabling in-house comprehensive genomic profiling for today's and tomorrow's clinical needs
28. 03. 2022 - WEBINAR: Illumina VIP Event
21. 03. 2022 - WEBINAR: Spatiotemporal analysis of cardiac tissue during myocardial infarction
14. 03. 2022 - Scaling to the cloud to support whole-genome sequencing
08. 03. 2022 - Skis, Skincare, and More: Making Better Products with Algae
21. 02. 2022 - From Patents to Patients: Meet the Women Making a Difference at Illumina
14. 02. 2022 - Patient Success Story: Beating Stage IV Lung Cancer
07. 02. 2022 - Illumina and Boehringer Ingelheim Announce Companion Diagnostic Partnership
01. 02. 2022 - Let it Grow: A DNA Database for Plants, One Species at a Time
26. 01. 2022 - 2021 in Genomics
18. 01. 2022 - Laboratóriumi folyadékkezelő automatizálási megoldások
18. 11. 2020 - WEBINAR for ALL: Single cell sequencing and spatial transcriptomics - Nov. 23-rd, 14:00
04. 11. 2020 - Az Illumina 2020 őszi virtuális eseményei !
27. 10. 2020 - ASHG’s Annual Meeting Goes Virtual
22. 10. 2020 - Delivering high-confidence DNA variant, RNA fusion and TMB data
15. 10. 2020 - Exploring Immunity—Linking Highly Multiplexed Antigen Recognition to Immune Repertoire and Phenotype
25. 09. 2020 - Using Single-Cell Multiomics to Reveal New Insights into Uveal Melanoma Evolution
22. 09. 2020 - Oncology variant interpretation just got more precise
23. 01. 2017 - Illumina - Egy új korszak kezdete a szekvenálásban!
Banner 4
Banner 5
10x_Logo_Horizontal_Full_Color_Digital2.png Arrow-logo2.png CovarisLogo_Pantone300C2.png diagenode_logo2.png DNA_D_(002)4.png Logo-IAB-poz2.png illumina3.png Invivoscribe.png LCG_315x78px.png Pillar-Logo2.png logo_seqone_(003)2.png Vitrolife_logo_CMYK1.PNG YourgeneHealth_logo3.png
Copyright © 2023 GeneTiCA Kft. +36 244 06 607 | genetica@genetica.hu